{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:02:22Z","timestamp":1777982542300,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>For those with a life-limiting illness, advance care planning (ACP) is essential for patient-centered care. However, there is limited research available on the timing and impact of ACP on patients with brain tumors, particularly with glioblastoma. The primary aim of this study was to determine if there is a relationship between advance directive (AD) documentation, a part of ACP, and depression, performance status scores, or demographics of patients with glioblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The sample consisted of 146 patients with glioblastoma, 98 of whom had documented AD, defined as within the 14\u00a0days prior to diagnosis or during their disease course, at a single comprehensive cancer center. Demographic characteristics, depression scores, performance status scores, and AD documentation were extracted from electronic medical records over repeated clinical time points. Logistic regression, mixed model, and generalized estimating equations models were used to assess relationships between patient variables and documentation of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No statistically significant difference in depression scores was found between those with and without documented AD. There was a statistically significant difference in performance status, such that those with worse performance status were more likely to have a documented AD. Patients who were female, older, and not married were more likely to have documented AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In our sample, AD was more likely to be established for patients with advanced disease and specific demographic factors, whereas depression scores did not predict presence or absence of AD. This may indicate that patients with decreased performance status may be more receptive to completing AD than those with better performance status. Alternatively, it could reflect that providers are more likely to approach the subject as their health deteriorates. Patients preparing for neurosurgical intervention might be more receptive to AD completion and ACP discussion than patients in other phases of care. We offer recommendations to promote a more proactive approach to AD so that more patients are prepared by the time their performance status starts to decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10492-6","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:33:22Z","timestamp":1771958002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of performance status, depression, and demographics with advance directive documentation in patients with glioblastoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Heather","family":"Niccum Haag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lambrecht-Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlton G.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loraine T.","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Flora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"10492_CR1","unstructured":"National Cancer Institute. Cancer of the brain and other nervous system - cancer stat facts. Surveillance, Epidemiology, and End Results Program Web site.\u00a0https:\/\/seer.cancer.gov\/statfacts\/html\/brain.html. Accessed\u00a0 6\u00a0June 2025."},{"key":"10492_CR2","unstructured":"\u200bAmerican Association of Neurological Surgeons. Glioblastoma multiforme. American Association of Neurological Surgeons Web site. \nhttps:\/\/www.aans.org\/patients\/conditions-treatments\/glioblastoma-multiforme\/#:~:text=Glioblastoma%20is%20the%20most%20common,of%203.21%20per%20100%2C000%20population. Updated 2024. Accessed 6 June 2025"},{"key":"10492_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133161","author":"NF Brown","year":"2022","unstructured":"Brown NF, Ottaviani D, Tazare J et al (2022) Survival outcomes and prognostic factors in glioblastoma. Cancers. https:\/\/doi.org\/10.3390\/cancers14133161","journal-title":"Cancers"},{"key":"10492_CR4","doi-asserted-by":"publisher","unstructured":"Ayoobkhan FS, Ganiyani MA, Pustake M et al (2024) Demographic disparities influencing survival of patients with glioblastoma. J Clin Oncol 42(16_suppl):e1379. \nhttps:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.e1379","DOI":"10.1200\/JCO.2024.42.16_suppl.e1379"},{"issue":"10","key":"10492_CR5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1177\/1049909118761094","volume":"35","author":"KO Moss","year":"2018","unstructured":"Moss KO, Deutsch NL, Hollen PJ, Rovnyak VG, Williams IC, Rose KM (2018) End-of-life plans for African American older adults with dementia. Am J Hosp Palliat Care 35(10):1314. https:\/\/doi.org\/10.1177\/1049909118761094","journal-title":"Am J Hosp Palliat Care"},{"issue":"8","key":"10492_CR6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/geronb\/gbac003","volume":"77","author":"Y Lou","year":"2022","unstructured":"Lou Y, Carr D (2022) Racial and ethnic disparities in advance care planning: assessing the role of subjective life expectancy. J Gerontol B Psychol Sci Soc Sci 77(8):1508. https:\/\/doi.org\/10.1093\/geronb\/gbac003","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"1","key":"10492_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.amepre.2013.09.008","volume":"46","author":"JK Rao","year":"2014","unstructured":"Rao JK, Anderson LA, Lin FC, Laux JP (2014) Completion of advance directives among U.S. consumers. Am J Prev Med 46(1):65\u201370. https:\/\/doi.org\/10.1016\/j.amepre.2013.09.008","journal-title":"Am J Prev Med"},{"key":"10492_CR8","doi-asserted-by":"publisher","unstructured":"Wu A, Ruiz Colon G, Aslakson R, Pollom E, Patel CB (2021) Palliative care service utilization and advance care planning for adult glioblastoma patients: a systematic review. Cancers (Basel) 13(12):2867. https:\/\/doi.org\/10.3390\/cancers13122867","DOI":"10.3390\/cancers13122867"},{"issue":"2","key":"10492_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejca.2011.11.010","volume":"48","author":"EM Sizoo","year":"2012","unstructured":"Sizoo EM, Pasman HR, Buttolo J et al (2012) Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer 48(2):226\u2013232. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.010","journal-title":"Eur J Cancer"},{"issue":"9","key":"10492_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00520-009-0735-y","volume":"18","author":"C Ostgathe","year":"2009","unstructured":"Ostgathe C, Gaertner J, Kotterba M et al (2009) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18(9):1157. https:\/\/doi.org\/10.1007\/s00520-009-0735-y","journal-title":"Support Care Cancer"},{"issue":"2","key":"10492_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1634\/theoncologist.2012-0247","volume":"18","author":"EM Sizoo","year":"2013","unstructured":"Sizoo EM, Taphoorn MJ, Uitdehaag B et al (2013) The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist 18(2):198\u2013203. https:\/\/doi.org\/10.1634\/theoncologist.2012-0247","journal-title":"Oncologist"},{"key":"10492_CR12","doi-asserted-by":"publisher","unstructured":"Fritz L, Dirven L, Reijneveld JC et al (2016) Advance care planning in glioblastoma patients. Cancers (Basel) 8(11). https:\/\/doi.org\/10.3390\/cancers8110102","DOI":"10.3390\/cancers8110102"},{"issue":"11","key":"10492_CR13","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1111\/jgs.16754","volume":"68","author":"RD McMahan","year":"2020","unstructured":"McMahan RD, Barnes DE, Ritchie CS et al (2020) Anxious, depressed, and planning for the future: advance care planning in diverse older adults. J Am Geriatr Soc 68(11):2638\u20132642. https:\/\/doi.org\/10.1111\/jgs.16754","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10492_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-017-2487-8","volume":"134","author":"KE Kuchinad","year":"2017","unstructured":"Kuchinad KE, Strowd R, Evans A, Riley WA, Smith TJ (2017) End of life care for glioblastoma patients at a large academic cancer center. J Neurooncol 134(1):75\u201381. https:\/\/doi.org\/10.1007\/s11060-017-2487-8","journal-title":"J Neurooncol"},{"issue":"2","key":"10492_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpainsymman.2012.08.009","volume":"46","author":"JV Poulose","year":"2013","unstructured":"Poulose JV, Do YK, Neo PSH (2013) Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service. J Pain Symptom Manage 46(2):173. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.08.009","journal-title":"J Pain Symptom Manage"},{"issue":"27","key":"10492_CR16","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1200\/JCO.2013.49.6562","volume":"31","author":"P Kumar","year":"2013","unstructured":"Kumar P, Temel JS (2013) End-of-life care discussions in patients with advanced cancer. J Clin Oncol 31(27):3315\u20133319. https:\/\/doi.org\/10.1200\/JCO.2013.49.6562","journal-title":"J Clin Oncol"},{"key":"10492_CR17","doi-asserted-by":"crossref","unstructured":"Ellsworth SG. Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution. Int J Radiat Oncol Biol Phys\u00a08;89(5):1100\u20131105","DOI":"10.1016\/j.ijrobp.2014.04.028"},{"issue":"11","key":"10492_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/10499091231154606","volume":"40","author":"N Dussault","year":"2023","unstructured":"Dussault N, Nickolopoulos E, Henderson K, Hemming P, Cho A, Ma JE (2023) Internal medicine resident barriers to advance care planning in the primary care continuity clinic. Am J Hosp Palliat Care 40(11):1205. https:\/\/doi.org\/10.1177\/10499091231154606","journal-title":"Am J Hosp Palliat Care"},{"key":"10492_CR19","doi-asserted-by":"publisher","unstructured":"Fu X, Wu C, Han N, et al. Depressive and anxiety disorders worsen the prognosis of glioblastoma. Aging (Albany NY). 2020;12(20):20095\u201320110. https:\/\/doi.org\/10.18632\/aging.103593","DOI":"10.18632\/aging.103593"},{"key":"10492_CR20","doi-asserted-by":"publisher","unstructured":"Rooney AG, McNamara S, Mackinnon M, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro Oncol. 2013;15(1):122\u2013129. https:\/\/doi.org\/10.1093\/neuonc\/nos282","DOI":"10.1093\/neuonc\/nos282"},{"key":"10492_CR21","doi-asserted-by":"publisher","unstructured":"Gately L, McLachlan SA, Dowling A, Philip J (2020) Surviving glioblastoma and a sense of disconnection. J Clin Neurosci 81:284\u2013289. https:\/\/doi.org\/10.1016\/j.jocn.2020.10.012","DOI":"10.1016\/j.jocn.2020.10.012"},{"key":"10492_CR22","doi-asserted-by":"publisher","unstructured":"Arch JJ, Bright EE, Finkelstein LB et al (2023) Anxiety and depression in metastatic cancer: a critical review of negative impacts on advance care planning and end-of-life decision making with practical recommendations. JCO Oncol Pract 19(12):1097. https:\/\/doi.org\/10.1200\/op.23.00287","DOI":"10.1200\/op.23.00287"},{"key":"10492_CR23","doi-asserted-by":"publisher","unstructured":"Fu X, Wu C, Han N et al (2020) Depressive and anxiety disorders worsen the prognosis of glioblastoma. Aging (Albany NY) 12(20):20095\u201320110. https:\/\/doi.org\/10.18632\/aging.103593","DOI":"10.18632\/aging.103593"},{"issue":"3","key":"10492_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14475\/jhpc.2021.24.3.144","volume":"24","author":"Y Yeun","year":"2021","unstructured":"Yeun Y (2021) The effects of advance care planning on decision conflict and psychological distress: a systematic review and meta-analysis of randomized controlled trials. Korean J Hosp Palliat Care 24(3):144. https:\/\/doi.org\/10.14475\/jhpc.2021.24.3.144","journal-title":"Korean J Hosp Palliat Care"},{"issue":"1","key":"10492_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/ane.13625","volume":"146","author":"P Stahl","year":"2022","unstructured":"Stahl P, Henoch I, Smits A, Rydenhag B, Ozanne A (2022) Quality of life in patients with glioblastoma and their relatives. Acta Neurol Scand 146(1):82\u201391. https:\/\/doi.org\/10.1111\/ane.13625","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10492_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jamaoncol.2015.311","volume":"1","author":"HJ West","year":"2015","unstructured":"West HJ, Jin JO (2015) JAMA oncology patient page. Performance status in patients with cancer. JAMA Oncol 1(7):998. https:\/\/doi.org\/10.1001\/jamaoncol.2015.311","journal-title":"JAMA Oncol"},{"issue":"2","key":"10492_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3349\/ymj.2018.59.2.194","volume":"59","author":"J Lee","year":"2018","unstructured":"Lee J, Ahn SS, Chang JH, Suh CO (2018) Hypofractionated re-irradiation after maximal surgical resection for recurrent glioblastoma: therapeutic adequacy and its prognosticators of survival. Yonsei Med J 59(2):194\u2013201. https:\/\/doi.org\/10.3349\/ymj.2018.59.2.194","journal-title":"Yonsei Med J"},{"issue":"5","key":"10492_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3171\/2017.6.JNS17393","volume":"129","author":"DA Goldman","year":"2018","unstructured":"Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg 129(5):1231\u20131239. https:\/\/doi.org\/10.3171\/2017.6.JNS17393","journal-title":"J Neurosurg"},{"key":"10492_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6511-6","author":"J Liang","year":"2020","unstructured":"Liang J, Lv X, Lu C (2020) Prognostic factors of patients with gliomas \u2013 an analysis on 335 patients with glioblastoma and other forms of gliomas. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-019-6511-6","journal-title":"BMC Cancer"},{"key":"10492_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179714","author":"SI Papacocea","year":"2024","unstructured":"Papacocea SI, Vrinceanu D, Dumitru M, Manole F, Serboiu C, Papacocea MT (2024) Molecular profile as an outcome predictor in glioblastoma along with MRI features and surgical resection: a scoping review. IJMS. https:\/\/doi.org\/10.3390\/ijms25179714","journal-title":"IJMS"},{"key":"10492_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032748","author":"AS Pidani","year":"2020","unstructured":"Pidani AS, Siddiqui AR, Azam I, Shamim MS, Jabbar AA, Khan S (2020) Depression among adult patients with primary brain tumour: a cross-sectional study of risk factors in a low\u2013middle-income country. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2019-032748","journal-title":"BMJ Open"},{"key":"10492_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.1069709","author":"X Wu","year":"2023","unstructured":"Wu X, Wang D, Wang D (2023) Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients. Front Surg. https:\/\/doi.org\/10.3389\/fsurg.2022.1069709","journal-title":"Front Surg"},{"issue":"2","key":"10492_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"9","key":"10492_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"10492_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41560-0","author":"A Gonz\u00e1lez-S\u00e1nchez","year":"2023","unstructured":"Gonz\u00e1lez-S\u00e1nchez A, Ortega-Moreno R, Villegas-Barahona G, Carazo-Vargas E, Arias-Leclaire H, Vicente-Galindo P (2023) New cut-off points of PHQ-9 and its variants, in Costa Rica: a nationwide observational study. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-41560-0","journal-title":"Sci Rep"},{"key":"10492_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2024.1259997","author":"JI Hlynsson","year":"2024","unstructured":"Hlynsson JI, Carlbring P (2024) Diagnostic accuracy and clinical utility of the PHQ-2 and GAD-2: a comparison with long-format measures for depression and anxiety. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2024.1259997","journal-title":"Front Psychol"},{"key":"10492_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6504","author":"B Levis","year":"2020","unstructured":"Levis B, Sun Y, He C et al (2020) Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.6504","journal-title":"JAMA"},{"issue":"9","key":"10492_CR38","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53(9):2002\u20132007. https:\/\/doi.org\/10.1002\/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w","journal-title":"Cancer"},{"key":"10492_CR39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66226","author":"S Sasaki","year":"2024","unstructured":"Sasaki S, Tsukamoto S, Ishida Y et al (2024) The karnofsky performance status at discharge is a prognostic indicator of life expectancy in patients with glioblastoma. Cureus. https:\/\/doi.org\/10.7759\/cureus.66226","journal-title":"Cureus"},{"key":"10492_CR40","doi-asserted-by":"crossref","unstructured":"Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42(1):121\u2013130","DOI":"10.2307\/2531248"},{"key":"10492_CR41","unstructured":"Ohio annual cancer report. 2021Ohio Department of Health Web site. https:\/\/aging.ohio.gov\/wps\/wcm\/connect\/gov\/cf65b125-2c5c-4f67-9a3d-955f0b6cca45\/Ohio+Annual+Cancer+Report+2021.pdf?MOD=AJPERES. Updated 2021. Accessed 22 April 2025"},{"issue":"3","key":"10492_CR42","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1016\/j.jpainsymman.2021.04.025","volume":"62","author":"T Jones","year":"2021","unstructured":"Jones T, Luth EA, Lin S, Brody AA (2021) Advance care planning, palliative care, and end-of-life care interventions for racial and ethnic underrepresented groups: a systematic review. J Pain Symptom Manage 62(3):e248. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.04.025","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10492_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/nop\/npac050","volume":"9","author":"L Fritz","year":"2022","unstructured":"Fritz L, Peeters MCM, Zwinkels H et al (2022) Advance care planning (ACP) in glioblastoma patients: evaluation of a disease-specific ACP program and impact on outcomes. Neuro-Oncol Pract 9(6):496. https:\/\/doi.org\/10.1093\/nop\/npac050","journal-title":"Neuro-Oncol Pract"},{"key":"10492_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104678","author":"M Tan","year":"2024","unstructured":"Tan M, Ding J, Johnson CE et al (2024) Stages of readiness for advance care planning: systematic review and meta-analysis of prevalence rates and associated factors. Int J Nurs Stud. https:\/\/doi.org\/10.1016\/j.ijnurstu.2023.104678","journal-title":"Int J Nurs Stud"},{"key":"10492_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101155","author":"L Grassi","year":"2023","unstructured":"Grassi L, Caruso R, Riba MB et al (2023) Anxiety and depression in adult cancer patients: ESMO clinical practice guideline. ESMO Open. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101155","journal-title":"ESMO Open"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10492-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:27Z","timestamp":1773215127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10492-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10492"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10492-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6969052\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}